期刊文献+

原发性肝癌患者肝动脉化疗栓塞术后复发的危险因素分析 被引量:1

下载PDF
导出
摘要 目的探究原发性肝癌患者肝动脉化疗栓塞术后复发的危险因素。方法采用方便抽样法,选取2018年1月—2021年6月本院收治的170例原发性肝癌患者为研究对象,回顾性收集患者的临床资料,根据患者复发情况分为复发组(n=101)和未复发组(n=69)。通过单因素分析及多因素Logistic回归分析法分析原发性肝癌患者肝动脉化疗栓塞术后复发的危险因素。结果170例原发性肝癌患者肝动脉化疗栓塞术后6个月复发101例,复发率为59.41%。多因素Logistic回归分析结果显示,肿瘤分化程度、肿瘤数目、血管侵犯情况、血浆甲胎蛋白(AFP)水平、血清白蛋白(ALB)水平是原发性肝癌患者肝动脉化疗栓塞术后复发的危险因素(P<0.05)。结论原发性肝癌患者肝动脉化疗栓塞术后复发风险较高,肿瘤分化程度低、血管侵犯、多发性肿瘤、血浆AFP>400 ng/mL、血清ALB≤30 g/L是原发性肝癌患者肝动脉化疗栓塞术后复发的危险因素。
作者 谢秋霞
出处 《当代护士(上旬刊)》 2023年第6期39-41,共3页 Modern Nurse
  • 相关文献

参考文献13

二级参考文献103

  • 1WHO handbook for reporting results of cancer treatment . Geneva (Switzerland): World Health Organization Offset Publication No.1979;48
  • 2Salni, S. Radiologic Measurement of Tumor Size in Clinical Trials:Past, Present, and Future. AJR, 2001; 176:333 - 334
  • 3Ross, B.D, Moffat, etal. Evaluation of Cancer Therapy UsingDiffusion Magnetic Resonance Imaging. Mol Cancer Ther, 2003; 2:581 -587
  • 4Fox, E, Curt, G. A, et al. Clinical Trial Design for Target-Based Therapy. Oncologist, 2002;7:401 - 409
  • 5Schwartz, L. H. Mazumdar. Brown. Variability in Response Assessment in Solid Tumors: Effect of Number of Lesions Chosen for Measurement. Clin Cancer Res, 2003;9:4318-4323
  • 6Park, J.O, Lee, et al. Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria. Jpn. J Clin. Oncol,2003; 33: 533 - 537
  • 7Gehan, E. A, Tefft, M.C. Will There Be Resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? J Natl Cancer Inst,2000;92:179 - 181
  • 8Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer, 1981;47:207-214
  • 9Warr D, McKinney S, Tannock I. Influence of measurement error on response rates, Cancer Treat Reg, 1985;69:1127- 1130
  • 10C, ehen. M Schneideremann. Historial and methodological developments in clinical trail at the national cancer institute. Stat Med, 1990;9:871- 880

共引文献402

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部